KREBS BIOCHEMICALS share price has plunged 6% and is presently trading at Rs 60.0.
Meanwhile, the BSE HEALTHCARE index is at 49,558.3 (up 0.5%).
Among the top losers in the BSE HEALTHCARE index today are J.B.Chemicals (down 3.7%) and METROPOLIS HEALTHCARE (down 2.3%).
LAURUS LABS (up 2.4%) and SUN PHARMA ADV. RES. (up 2.3%) are among the top gainers today.
Over the last one year, KREBS BIOCHEMICALS has moved down from Rs 71.0 to Rs 60.0, registering a loss of Rs 11.0 (down 15.5%).
On the other hand, the BSE HEALTHCARE index has moved up from 43,982.5 to 49,558.3, registering a gain of 12.7% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were LAURUS LABS (up 133.0%), Divis Laboratories (up 60.2%) and Aurobindo Pharma (up 54.4%).
Discover: Where the opportunities are emerging for the next 3-5 years
The BSE Sensex is at 72,747.9 (up 0.5%).
The top gainers among the BSE Sensex today are Kotak Bank (up 3.5%) and Indusind Bank (up 2.0%). The most traded stocks in the BSE Sensex are ITC and Kotak Bank.
In the meantime, NSE Nifty is at 22,670.4 (up 0.5%). Trent and Kotak Bank are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved down from 81,790.1 to 72,747.9, registering a loss of 9,042.3 points (down 11.1%).
KREBS BIOCHEMICALS net profit grew 53.3% YoY to Rs -25 million for the quarter ended June 2026, compared to a loss of Rs 53 million a year ago. Net sales rose 27.4% to Rs 70 million during the period as against Rs 55 million in April-June 2025.
For the year ended March 2026, KREBS BIOCHEMICALS reported 37.1% increase in net profit to Rs -169 million compared to net loss of Rs 269 million during FY25. Revenue of the company fell 45.2% to Rs 237 million during FY26.
The current Price to earnings ratio of KREBS BIOCHEMICALS, based on rolling 12 month earnings, stands at -9.2.
Image source: phive2015/www.istockphoto.com
Equitymaster requests your view! Post a comment on "KREBS BIOCHEMICALS Plunges 6%; BSE HEALTHCARE Index Up 0.5%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!